图书馆订阅: Guest
Begell Digital Portal Begell 数字图书馆 电子图书 期刊 参考文献及会议录 研究收集
医药载体系统评论综述
影响因子: 2.9 5年影响因子: 3.72 SJR: 0.736 SNIP: 0.818 CiteScore™: 4.6

ISSN 打印: 0743-4863
ISSN 在线: 2162-660X

医药载体系统评论综述

DOI: 10.1615/CritRevTherDrugCarrierSyst.2013005268
pages 183-216

Psoriasis Clinical Implications and Treatment: A Review

Ashlesha S. Raut
Department of Pharmaceutical Sciences and Technology, Institute of Chemical Technology, Nathalal Parekh Marg, Matunga, Mumbai 400 019, India
Rashmi H. Prabhu
Department of Pharmaceutical Sciences and Technology, Institute of Chemical Technology, Nathalal Parekh Marg, Matunga, Mumbai 400 019, India
Vandana B. Patravale
Department of Pharmaceutical Sciences and Technology, Institute of Chemical Technology, Nathalal Parekh Marg, Matunga, Mumbai, Maharashtra, India

ABSTRACT

Psoriasis is a common skin disorder affecting the population worldwide. It is a T-cell mediated autoimmune disorder leading to keratinocyte hyperproliferation. Psoriasis has genetic predisposition that is further aggravated by certain stimulating factors. In spite of significant advances in understanding the pathogenesis of psoriasis, the exact etiology of the disease remains unknown. The clinical manifestations of this disease include various forms that affect different parts of the body. Treatment options vary according to the mode of application or severity of the disease. Earlier treatments have included application of emollients or keratolytic agents to hydrate the skin or shed off the skin. But later treatments have been modified to treat the underlying T-cell proliferation. Hence, topical treatments like coal tar, vitamin D, retinoids, topical calcineurin inhibitors for treating mild psoriasis, systemic treatments including methotrexate, cyclosporine, acitretin, hydroxyurea, as well as light therapy for severe psoriasis have become more prominent. Current treatment modalities are associated with the risk of serious side effects from prolonged treatment. Combinations of these therapies have provided effective and rapid modalities to suppress the disease and reduce the side effects of treatment. In addition, newer carrier systems for conventional drugs are being developed to improve the effectiveness of treatment and reduce the side effects. Development of biologics and gene therapy have revolutionized the treatment of this skin disease. Although an array of therapies to suppress the psoriatic condition exists, none are curative.


Articles with similar content:

Ancient and Advanced Approaches for the Treatment of an Inflammatory Autoimmune Disease−Psoriasis
Critical Reviews™ in Therapeutic Drug Carrier Systems, Vol.31, 2014, issue 4
Goutam Rath, Tarun Garg, Amit Kumar Goyal
Current Perspectives in Immunotherapy for Liver Cancer
Critical Reviews™ in Oncogenesis, Vol.25, 2020, issue 1
Bassam Ghabach, Kalyani Narra, Riyaz Basha, Christoffer Briggs Lambring
Nail Psoriasis Treatment: Insights into Current Progress and Future Trends
Critical Reviews™ in Therapeutic Drug Carrier Systems, Vol.37, 2020, issue 2
Supriya Verma, Rajesh Singh Jadon, Gajanand Sharma, Pradip Nirbhavane, Bhupinder Singh, Om Parkash Katare
Options and Opportunities for Clinical Management and Treatment of Psoriasis
Critical Reviews™ in Therapeutic Drug Carrier Systems, Vol.30, 2013, issue 1
Udita Agrawal, Devyani Dube, Madhu Gupta, Suresh P. Vyas
Targeted Molecular Therapeutic Options for Hepatocellular Carcinoma
Critical Reviews™ in Oncogenesis, Vol.25, 2020, issue 1
Latha Neerukonda, Bassam Ghabach, Ishna Sharma, Kalyani Narra, Swathi Sridhar, Riyaz Basha, Umesh T. Sankpal